DR5; RB X-100UG

Code: AB16942 D2-231

Application

Research CategoryApoptosis & Cancer

Anti-DR5 Antibody, C-terminus detects level of DR5 & has been published & validated for use in WB.

Western blot: 1...


read more

Your Price
€430.00 EACH
€528.90 inc. VAT

Application

Research CategoryApoptosis & Cancer

Anti-DR5 Antibody, C-terminus detects level of DR5 & has been published & validated for use in WB.

Western blot: 1:250 to 1:500

Whole cell lysate from HeLa or K562 cells can be used as a positive control .

Optimal working dilutions must be determined by end user.

Research Sub CategoryApoptosis - Additional

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

Epitope: C-terminus

Polyclonal antibody raised against a peptide corresponding to amino acids 388-407 of human DR5 precursor (Pan et al. 1997; Sheridan et al. 1997).

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Physical form

Format: Purified

Affinity purified immunoglobulin. Liquid in PBS containing 0.02% sodium azide.

Specificity

Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family. DR4 was recently identified as the receptor for TRAIL. A novel death domain containing receptor for TRAIL was more recently identified and designated DR5, Apo2, TRAIL-R2, TRICK2 or KILLER by several groups independently (Pan et al. 1997; Sheridan et al. 1997; Walczak et al. 1997; MacFarlane et al. 1997; Screaton et al. 1997; Wu et al. 1997; Chaudhary et al. 1997). Like DR4, DR5 transcript is widely expressed in normal tissues and in many types of tumor cells. DR5 binds to TRAIL and mediates TRAIL induced cell death. Overexpression of DR5 induces apoptosis and activates NF-kB.

Storage and Stability

Maintain refrigerated at 2-8°C in undiluted aliquots for up to 12 months.

antibody formaffinity purified immunoglobulin
antibody product typeprimary antibodies
biological sourcerabbit
clonepolyclonal
Gene Informationhuman ... TNFRSF10B(8795)
manufacturer/tradenameChemicon®
NCBI accession no.NM_147187.1, NM_003842.3
Quality Level100
shipped inwet ice
species reactivityhuman
technique(s)western blot: suitable
UniProt accession no.O14763
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.